Joon S. Park-Cho

Yongin, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Differential glycemic effects of DWP16001 in diabetic dogs according to baseline glycemic status: a multicenter randomized controlled trial.

Differential glycemic effects of DWP16001 in diabetic dogs according to baseline glycemic status: a multicenter randomized controlled trial.

Journal: BMC veterinary research

Published: June 05, 2025

Restoration of intestinal barrier function by fexuprazan, a potassium-competitive acid blocker, in Caco-2 cells and its higher gastrointestinal distribution in rats.

Restoration of intestinal barrier function by fexuprazan, a potassium-competitive acid blocker, in Caco-2 cells and its higher gastrointestinal distribution in rats.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 21, 2025

Reverse translational approach to clarify the strong potency of enavogliflozin, a novel sodium-glucose cotransporter 2 inhibitor.

Reverse translational approach to clarify the strong potency of enavogliflozin, a novel sodium-glucose cotransporter 2 inhibitor.

Journal: The Journal of pharmacology and experimental therapeutics

Published: March 19, 2025

Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies.

Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies.

Journal: Diabetes & metabolism journal

Published: February 09, 2025

Mechanisms of glucagon-like-peptide 1 in the brain beyond metabolic effects.

Mechanisms of glucagon-like-peptide 1 in the brain beyond metabolic effects.

Journal: Annals of pediatric endocrinology & metabolism

Published: December 26, 2024

A normative framework dissociates need and motivation in hypothalamic neurons.

A normative framework dissociates need and motivation in hypothalamic neurons.

Journal: Science advances

Published: November 06, 2024

Prolyl-tRNA synthetase inhibitor as a novel first-in-class keloid treatment: downregulation of de novo collagen synthesis and inflammatory cascade.

Prolyl-tRNA synthetase inhibitor as a novel first-in-class keloid treatment: downregulation of de novo collagen synthesis and inflammatory cascade.

Journal: The British journal of dermatology

Published: October 07, 2024

GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans.

GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans.

Journal: Science (New York, N.Y.)

Published: June 27, 2024

EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis.

EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis.

Journal: Experimental & molecular medicine

Published: May 14, 2024

Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans.

Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans.

Journal: Pharmaceutics

Published: February 01, 2023

SGLT2 inhibition ameliorates nano plastics-induced premature endothelial senescence and dysfunction.

SGLT2 inhibition ameliorates nano plastics-induced premature endothelial senescence and dysfunction.

Journal: Scientific reports

Published: January 18, 2023

DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis.

DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis.

Journal: Diabetes & metabolism journal

Published: October 20, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026